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Abstract
Countries around the world are experiencing an ever-increasing need to make choices in investments in health 
and healthcare. This makes it incumbent upon them to have formal processes in place to optimize the legitimacy 
of eventual decisions. There is now growing experience among countries of the implementation of stakeholder 
participation, and a developing convergence of methods to support decision-makers within health authorities in 
making tough decisions when faced with the stark reality of limited resources. We call for further interaction 
among health authorities, and the research community to develop best practices in order to confront the difficult 
choices that need to be made. 
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Countries around the world experience an ever-increasing need to make choices in healthcare. In high-income countries, the rapid development 
of expensive new drugs demands a growing share of the 
available budgets. For example, in the United States, costs of 
the drug Sovaldi for the treatment of Hepatitis C are as high 
as US$84 000 per patient, and may amount to a total budget 
impact of US$65 billion in the next 5 years.1 Coupled with 
rising public expectations and fiscal austerity, this leads to a 
situation of fiercely competing demands on available budgets. 
Lower-income countries, having a higher burden of disease 
but lower available budgets, are even more challenged on their 
path towards universal health coverage.2 
In this context, more than 200 delegates from 22 countries 
convened in September 2016 in Birmingham, UK, at the 11th 
International Conference on Priorities in Health. Academics 
from various disciplines including medicine, ethics, public 
health, health economics, political and management sciences, 
together with policy-makers and patients, discussed best 
practices for setting priorities to inform coverage decisions on 
health interventions. Discussions at the conference centred 
around four themes.
Firstly, as signalled in a recent World Health Organization 
(WHO) survey among 111 countries, the majority of 
countries has formal processes in place to collect and analyse 
information for making coverage decisions.3  Yet, many nations 
still lack well-defined processes for considering evidence in 
decision-making. Their coverage decisions are therefore at 
risk of being ad-hoc and difficult to justify. At the conference, 
a pervasive message for health authorities in countries around 
the world was to put formal processes in place. 
Second, health authorities use different criteria in these formal 
processes. The WHO survey reported that in making coverage 
decisions on pharmaceuticals, most countries ‘always or 
almost always’ considered safety and clinical effectiveness. 
Yet, less than half of countries considered economic 
aspects, and only a few countries considered acceptability to 
healthcare providers and patients, equity issues, ethical issues 
and feasibility considerations as such.3 At the conference, it 
was emphasised that countries can learn from each others’ 
experiences on the use of criteria for coverage decisions, as 
well as from international recommendations.2
Third, countries make different choices on how they 
organise their processes, for example in terms of stakeholder 
involvement of patients and health professionals, 
transparency of the process, and whether or not to allow 
for appeals. If processes omit stakeholder involvement 
and/or lack transparency this can compromise the extent 
to which members of society accept health authorities 
as moral authorities, and whether they consider health 
authority decisions to be legitimate. The growing litigation 
in a country like Mexico, where citizens challenge negative 
reimbursement decisions on health interventions as taken by 
health authorities in court in order to acquire access to these 
interventions, may be seen as a manifestation of this.4 At the 
conference, meaningful stakeholder involvement was stressed 
as an important prerequisite for coverage decision-making, as 
was the need to design health authorities with the necessary 
resources and credibility to make defensible decisions.5 Again, 
countries can learn from each others’ processes, and the work 
of the International Decisions Support Initiative6 in lower-
income countries and the European Network on Health 
Technology Assessment7 are both instrumental in this respect.
Fourth, there is a developing convergence of methods to 
support authorities in setting priorities. Cost-effectiveness 
analysis (CEA) has long been the principal method for doing 
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so, and remains relevant. Yet, the use of CEA for priority 
setting is increasingly being cited for its narrow emphasis on 
efficiency, and as such, for insufficiently taking into account 
other relevant stakeholder values.8 At the same time, ethical 
frameworks for priority setting have been developed, centred 
around stakeholder deliberation.9 These twin issues are being 
addressed currently through a range of methods that can be 
classified under the general heading of ‘evidence-informed 
deliberative processes.’8,10,11 The methods, are, on the one 
hand, based on deliberation between stakeholders to identify, 
reflect and learn about the meaning and importance of their 
respective values. On the other hand, they are based on 
rational decision-making – this involves the interpretation of 
evidence that is available (or is being additionally collected), 
and which may further shape the deliberation on the values. 
An important principle here is evidence-informed evaluation, 
which allows contributions of stakeholders in terms of their 
personal) experiences and judgments.8 At the conference, 
delegates considered this developing convergence on methods 
and its broad implementation as highly encouraging. Yet, 
it should be realized that priority setting is not only about 
developments of methods. It is also about how to create 
the context where these are used – eg, the organisation, 
development and building of institutions and institutional 
support systems, and management of power relations.12,13
In summary, the pressing need for nations to allocate resources 
such that health is maximized in a fashion that is acceptable 
to its populations makes it incumbent upon countries to 
have formal processes in place to optimize the legitimacy of 
eventual decisions. There is now growing experience among 
countries of the implementation of such processes, and a 
developing convergence of methods to support decision-
makers within health authorities in making tough decisions 
when faced with the stark reality of limited resources. We 
call for further interaction among health authorities and the 
research community to develop best practices in order to 
confront the difficult choices that need to be made.
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